CTP sensing and Mec1ATR-Rad53CHK1/CHK2 mediate a two-layered response to inhibition of glutamine metabolism.
Glutamine analogs are potent suppressors of general glutamine metabolism with anti-cancer activity. 6-diazo-5-oxo-L-norleucine (DON) is an orally available glutamine analog which has been recently improved by structural modification for cancer treatment. Here, we explored the chemogenomic landscape...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-03-01
|
| Series: | PLoS Genetics |
| Online Access: | https://doi.org/10.1371/journal.pgen.1010101 |
| _version_ | 1818314672692002816 |
|---|---|
| author | Arta Ajazi Ramveer Choudhary Laura Tronci Angela Bachi Christopher Bruhn |
| author_facet | Arta Ajazi Ramveer Choudhary Laura Tronci Angela Bachi Christopher Bruhn |
| author_sort | Arta Ajazi |
| collection | DOAJ |
| description | Glutamine analogs are potent suppressors of general glutamine metabolism with anti-cancer activity. 6-diazo-5-oxo-L-norleucine (DON) is an orally available glutamine analog which has been recently improved by structural modification for cancer treatment. Here, we explored the chemogenomic landscape of DON sensitivity using budding yeast as model organism. We identify evolutionarily conserved proteins that mediate cell resistance to glutamine analogs, namely Ura8CTPS1/2, Hpt1HPRT1, Mec1ATR, Rad53CHK1/CHK2 and Rtg1. We describe a function of Ura8 as inducible CTP synthase responding to inhibition of glutamine metabolism and propose a model for its regulation by CTP levels and Nrd1-dependent transcription termination at a cryptic unstable transcript. Disruption of the inducible CTP synthase under DON exposure hyper-activates the Mec1-Rad53 DNA damage response (DDR) pathway, which prevents chromosome breakage. Simultaneous inhibition of CTP synthase and Mec1 kinase synergistically sensitizes cells to DON, whereas CTP synthase over-expression hampers DDR mutant sensitivity. Using genome-wide suppressor screening, we identify factors promoting DON-induced CTP depletion (TORC1, glutamine transporter) and DNA breakage in DDR mutants. Together, our results identify CTP regulation and the Mec1-Rad53 DDR axis as key glutamine analog response pathways, and provide a rationale for the combined targeting of glutamine and CTP metabolism in DDR-deficient cancers. |
| first_indexed | 2024-12-13T08:53:22Z |
| format | Article |
| id | doaj.art-296f23734628430b860c2dde0b4beb70 |
| institution | Directory Open Access Journal |
| issn | 1553-7390 1553-7404 |
| language | English |
| last_indexed | 2024-12-13T08:53:22Z |
| publishDate | 2022-03-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Genetics |
| spelling | doaj.art-296f23734628430b860c2dde0b4beb702022-12-21T23:53:19ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042022-03-01183e101010110.1371/journal.pgen.1010101CTP sensing and Mec1ATR-Rad53CHK1/CHK2 mediate a two-layered response to inhibition of glutamine metabolism.Arta AjaziRamveer ChoudharyLaura TronciAngela BachiChristopher BruhnGlutamine analogs are potent suppressors of general glutamine metabolism with anti-cancer activity. 6-diazo-5-oxo-L-norleucine (DON) is an orally available glutamine analog which has been recently improved by structural modification for cancer treatment. Here, we explored the chemogenomic landscape of DON sensitivity using budding yeast as model organism. We identify evolutionarily conserved proteins that mediate cell resistance to glutamine analogs, namely Ura8CTPS1/2, Hpt1HPRT1, Mec1ATR, Rad53CHK1/CHK2 and Rtg1. We describe a function of Ura8 as inducible CTP synthase responding to inhibition of glutamine metabolism and propose a model for its regulation by CTP levels and Nrd1-dependent transcription termination at a cryptic unstable transcript. Disruption of the inducible CTP synthase under DON exposure hyper-activates the Mec1-Rad53 DNA damage response (DDR) pathway, which prevents chromosome breakage. Simultaneous inhibition of CTP synthase and Mec1 kinase synergistically sensitizes cells to DON, whereas CTP synthase over-expression hampers DDR mutant sensitivity. Using genome-wide suppressor screening, we identify factors promoting DON-induced CTP depletion (TORC1, glutamine transporter) and DNA breakage in DDR mutants. Together, our results identify CTP regulation and the Mec1-Rad53 DDR axis as key glutamine analog response pathways, and provide a rationale for the combined targeting of glutamine and CTP metabolism in DDR-deficient cancers.https://doi.org/10.1371/journal.pgen.1010101 |
| spellingShingle | Arta Ajazi Ramveer Choudhary Laura Tronci Angela Bachi Christopher Bruhn CTP sensing and Mec1ATR-Rad53CHK1/CHK2 mediate a two-layered response to inhibition of glutamine metabolism. PLoS Genetics |
| title | CTP sensing and Mec1ATR-Rad53CHK1/CHK2 mediate a two-layered response to inhibition of glutamine metabolism. |
| title_full | CTP sensing and Mec1ATR-Rad53CHK1/CHK2 mediate a two-layered response to inhibition of glutamine metabolism. |
| title_fullStr | CTP sensing and Mec1ATR-Rad53CHK1/CHK2 mediate a two-layered response to inhibition of glutamine metabolism. |
| title_full_unstemmed | CTP sensing and Mec1ATR-Rad53CHK1/CHK2 mediate a two-layered response to inhibition of glutamine metabolism. |
| title_short | CTP sensing and Mec1ATR-Rad53CHK1/CHK2 mediate a two-layered response to inhibition of glutamine metabolism. |
| title_sort | ctp sensing and mec1atr rad53chk1 chk2 mediate a two layered response to inhibition of glutamine metabolism |
| url | https://doi.org/10.1371/journal.pgen.1010101 |
| work_keys_str_mv | AT artaajazi ctpsensingandmec1atrrad53chk1chk2mediateatwolayeredresponsetoinhibitionofglutaminemetabolism AT ramveerchoudhary ctpsensingandmec1atrrad53chk1chk2mediateatwolayeredresponsetoinhibitionofglutaminemetabolism AT lauratronci ctpsensingandmec1atrrad53chk1chk2mediateatwolayeredresponsetoinhibitionofglutaminemetabolism AT angelabachi ctpsensingandmec1atrrad53chk1chk2mediateatwolayeredresponsetoinhibitionofglutaminemetabolism AT christopherbruhn ctpsensingandmec1atrrad53chk1chk2mediateatwolayeredresponsetoinhibitionofglutaminemetabolism |